A detailed history of Transcend Capital Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 2,120 shares of ZTS stock, worth $345,411. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,120
Previous 2,111 0.43%
Holding current value
$345,411
Previous $365,000 13.42%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$172.58 - $196.48 $1,553 - $1,768
9 Added 0.43%
2,120 $414,000
Q2 2024

Jul 02, 2024

SELL
$145.54 - $178.83 $2,765 - $3,397
-19 Reduced 0.89%
2,111 $365,000
Q1 2024

May 03, 2024

BUY
$165.67 - $199.94 $28,660 - $34,589
173 Added 8.84%
2,130 $360,000
Q4 2023

Feb 05, 2024

BUY
$151.44 - $200.09 $18,930 - $25,011
125 Added 6.82%
1,957 $386,000
Q3 2023

Oct 31, 2023

BUY
$167.14 - $192.77 $79,725 - $91,951
477 Added 35.2%
1,832 $318,000
Q2 2023

Jul 13, 2023

SELL
$160.94 - $186.23 $5,311 - $6,145
-33 Reduced 2.38%
1,355 $233,000
Q1 2023

Apr 12, 2023

SELL
$145.48 - $175.02 $102,854 - $123,739
-707 Reduced 33.75%
1,388 $231,000
Q4 2022

Jan 20, 2023

BUY
$131.14 - $157.47 $64,127 - $77,002
489 Added 30.45%
2,095 $0
Q3 2022

Oct 17, 2022

SELL
$148.29 - $182.55 $10,232 - $12,595
-69 Reduced 4.12%
1,606 $238,000
Q2 2022

Jul 12, 2022

BUY
$155.97 - $200.09 $1,559 - $2,000
10 Added 0.6%
1,675 $288,000
Q1 2022

Apr 20, 2022

BUY
$181.39 - $234.03 $23,399 - $30,189
129 Added 8.4%
1,665 $314,000
Q3 2021

Nov 04, 2021

BUY
$189.29 - $209.69 $290,749 - $322,083
1,536 New
1,536 $323,000
Q2 2021

Aug 13, 2021

SELL
$155.9 - $187.99 $217,792 - $262,622
-1,397 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$144.0 - $169.39 $6,912 - $8,130
48 Added 3.56%
1,397 $219,000
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $211,887 - $235,198
1,349 New
1,349 $223,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.3B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.